167 results on '"McCullough, Arthur"'
Search Results
2. Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis
3. AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review
4. Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis
5. Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis
6. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype
7. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage
8. Obstructive Sleep Apnea and the Liver
9. Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis
10. Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits
11. Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease?
12. The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View
13. Stable isotope-based flux studies in nonalcoholic fatty liver disease
14. Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation
15. Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children
16. Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis
17. Acute Alcoholic Hepatitis, the Clinical Aspects
18. Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients
19. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
20. Prevalence of celiac disease in cirrhosis and outcome of cirrhosis on a gluten free diet: A prospective study
21. The Impact of Obesity and Metabolic Syndrome on Alcoholic Liver Disease
22. Population-Based Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults With Type 2 Diabetes
23. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease
24. High prevalence of normal serum albumin in NASH patients with ascites: A retrospective analysis
25. Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio
26. The Relevance of Liver Histology to Predicting Clinically Meaningful Outcomes in Nonalcoholic Steatohepatitis
27. Role of ceramides in nonalcoholic fatty liver disease
28. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
29. Impact of budesonide on liver function tests and gut inflammation in patients with primary sclerosing cholangitis and ileal pouch anal anastomosis
30. Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need for Colectomy in Patients With Ulcerative Colitis
31. OS-125 15-year liver outcomes after metabolic surgery in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH)
32. Sarcopenia associated with portosystemic shunting is reversed by follistatin
33. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
34. Plasma metabolomic profile in nonalcoholic fatty liver disease
35. Measuring protein synthesis using metabolic 2H labeling, high-resolution mass spectrometry, and an algorithm
36. Development of machine learning model to detect fibrotic non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
37. Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry
38. Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
39. Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
40. Predictors of Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
41. Ascitic Fluid Lactoferrin for Diagnosis of Spontaneous Bacterial Peritonitis
42. Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans
43. Nonalcoholic Steatohepatitis Decompensation and Portal Pressures
44. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
45. Su1520 LIVER TISSUE VS. PLASMA CERAMIDE ANALYSIS IN NONALCOHOLIC FATTY LIVER DISEASE: A POSSIBLE BIOMARKER AND TARGET FOR INTERVENTION
46. Inhibition of aromatase improves nutritional status following portacaval anastomosis in male rats
47. Improving compliance with postpolypectomy surveillance guidelines: an interventional study using a continuous quality improvement initiative
48. Chapter 5 - Dietary Manipulations for Nonalcoholic Fatty Liver Disease (NAFLD)
49. Nonalcoholic fatty liver disease in patients with type 2 diabetes
50. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.